Journal article
Untargeted Plasma Metabolomics Identifies Endogenous Metabolite with Drug-like Properties in Chronic Animal Model of Multiple Sclerosis
The Journal of biological chemistry, Vol.290(52), pp.30697-30712
12/25/2015
DOI: 10.1074/jbc.M115.679068
PMCID: PMC4692201
PMID: 26546682
Abstract
We performed untargeted metabolomics in plasma of B6 mice with experimental autoimmune encephalitis (EAE) at the chronic phase of the disease in search of an altered metabolic pathway(s). Of 324 metabolites measured, 100 metabolites that mapped to various pathways (mainly lipids) linked to mitochondrial function, inflammation, and membrane stability were observed to be significantly altered between EAE and control (p < 0.05, false discovery rate <0.10). Bioinformatics analysis revealed six metabolic pathways being impacted and altered in EAE, including α-linolenic acid and linoleic acid metabolism (PUFA). The metabolites of PUFAs, including ω-3 and ω-6 fatty acids, are commonly decreased in mouse models of multiple sclerosis (MS) and in patients with MS. Daily oral administration of resolvin D1, a downstream metabolite of ω-3, decreased disease progression by suppressing autoreactive T cells and inducing an M2 phenotype of monocytes/macrophages and resident brain microglial cells. This study provides a proof of principle for the application of metabolomics to identify an endogenous metabolite(s) possessing drug-like properties, which is assessed for therapy in preclinical mouse models of MS.
Details
- Title: Subtitle
- Untargeted Plasma Metabolomics Identifies Endogenous Metabolite with Drug-like Properties in Chronic Animal Model of Multiple Sclerosis
- Creators
- Laila M Poisson - From the Center for Bioinformatics and Departments of Public Health Sciences andHamid Suhail - Henry Ford Health SystemJaspreet Singh - Henry Ford Health SystemIndrani Datta - Henry Ford Health SystemAleksandar Denic - the Departments of Neurology andKrzysztof Labuzek - Medical University of SilesiaMd Nasrul Hoda - Augusta UniversityAshray Shankar - Henry Ford Health SystemAshok Kumar - University of IowaMirela Cerghet - Henry Ford Health SystemStanton Elias - Henry Ford HospitalRobert P Mohney - Metabolon (United States)Moses Rodriguez - Mayo ClinicRamandeep Rattan - Henry Ford Health SystemAshutosh K Mangalam - the Department of Pathology, University of Iowa Carver College of Medicine, Iowa City, Iowa 52242Shailendra Giri - Henry Ford Health System
- Resource Type
- Journal article
- Publication Details
- The Journal of biological chemistry, Vol.290(52), pp.30697-30712
- DOI
- 10.1074/jbc.M115.679068
- PMID
- 26546682
- PMCID
- PMC4692201
- NLM abbreviation
- J Biol Chem
- ISSN
- 0021-9258
- eISSN
- 1083-351X
- Publisher
- United States
- Grant note
- R01 GM092993 / NIGMS NIH HHS R01GM092993 / NIGMS NIH HHS
- Language
- English
- Date published
- 12/25/2015
- Academic Unit
- Pathology; Iowa Neuroscience Institute
- Record Identifier
- 9983905648102771
Metrics
90 Record Views